JPH0462026B2 - - Google Patents
Info
- Publication number
- JPH0462026B2 JPH0462026B2 JP3482784A JP3482784A JPH0462026B2 JP H0462026 B2 JPH0462026 B2 JP H0462026B2 JP 3482784 A JP3482784 A JP 3482784A JP 3482784 A JP3482784 A JP 3482784A JP H0462026 B2 JPH0462026 B2 JP H0462026B2
- Authority
- JP
- Japan
- Prior art keywords
- peroxidase
- reaction
- solution
- coloring
- hydrogen peroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 39
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 19
- 235000006408 oxalic acid Nutrition 0.000 claims description 13
- 239000003086 colorant Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 9
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 7
- 229920003169 water-soluble polymer Polymers 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 31
- 102000013415 peroxidase activity proteins Human genes 0.000 description 31
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 26
- 239000000126 substance Substances 0.000 description 20
- 238000006911 enzymatic reaction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 238000005259 measurement Methods 0.000 description 15
- 102000004877 Insulin Human genes 0.000 description 13
- 108090001061 Insulin Proteins 0.000 description 13
- 238000004040 coloring Methods 0.000 description 13
- 229940125396 insulin Drugs 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- 239000008363 phosphate buffer Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 206010029719 Nonspecific reaction Diseases 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000011088 calibration curve Methods 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 description 5
- 238000000691 measurement method Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- -1 hydrogen peroxide Chemical class 0.000 description 4
- 150000004986 phenylenediamines Chemical class 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 4
- 229940039790 sodium oxalate Drugs 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 3
- 108010017384 Blood Proteins Proteins 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 3
- 102000008857 Ferritin Human genes 0.000 description 3
- 108050000784 Ferritin Proteins 0.000 description 3
- 238000008416 Ferritin Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 102000011923 Thyrotropin Human genes 0.000 description 3
- 108010061174 Thyrotropin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000122 growth hormone Substances 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229940018564 m-phenylenediamine Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000007539 photo-oxidation reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- XBTWVJKPQPQTDW-UHFFFAOYSA-N 4-n,4-n-diethyl-2-methylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C(C)=C1 XBTWVJKPQPQTDW-UHFFFAOYSA-N 0.000 description 1
- QNGVNLMMEQUVQK-UHFFFAOYSA-N 4-n,4-n-diethylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C=C1 QNGVNLMMEQUVQK-UHFFFAOYSA-N 0.000 description 1
- UOWYGPTYSRURDP-UHFFFAOYSA-N 4-n,4-n-dipropylbenzene-1,4-diamine Chemical compound CCCN(CCC)C1=CC=C(N)C=C1 UOWYGPTYSRURDP-UHFFFAOYSA-N 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108010089254 Cholesterol oxidase Proteins 0.000 description 1
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex⢠Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N hydroxylamine group Chemical group NO AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 150000004989 p-phenylenediamines Chemical class 0.000 description 1
- 239000007981 phosphate-citrate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
æ¬çºæã¯å®å®ãªéé
žåç©è³ªãŸãã¯éé
žåé
µçŽ 掻
æ§æž¬å®è©Šè¬çšçºè²å€çµæç©ã«é¢ããããã«è©³ãã
ã¯éé
žåç©è³ªãŸãã¯éé
žåé
µçŽ ããã³çºè²å€çã
çšããé
žåçºè²ã«ãã枬å®ç³»ã«çšããçºè²å€ã®å®
å®åæ³ã«é¢ããã
éé
žåç©è³ªãç¹ã«éé
žåæ°ŽçŽ ã®æž¬å®ã¯æè¿ãèš
åºæ€æ»ã®åéã«ãããŠéèŠæ§ãå¢ãã€ã€ãããäœ
液æåãäŸãã°ãããŠç³ãå°¿é
žãã³ã¬ã¹ãããŒ
ã«ãã¢ãã¢ãã³ã¯ã°ã«ã³ãŒã¹ãªãã·ããŒãŒããŠãª
ã«ãŒãŒãã³ã«ã¹ãããŒã«ãªãã·ããŒãŒãã¢ãã¢ã
ã³ãªãã·ããŒãŒãšã®é
µçŽ åå¿ã«ãã€ãŠéé
žåæ°ŽçŽ
ãçæãããçæããéé
žåæ°ŽçŽ ã¯çºè²å€ããã³
éé
žåé
µçŽ ãçšããŠå®éããããšã«ãã€ãŠãåã
ã®äœæ¶²æåã®å«éãç¥ãããšãã§ããã
ãŸããéé
žåé
µçŽ ã®æŽ»æ§æž¬å®ã¯ãã«ãªãã·ããŒ
ãŒãæšèç©è³ªãšããé
µçŽ å
ç«æž¬å®æ³ã«ãããŠéèŠ
æ§ãå¢ãã€ã€ãããäžè¬ã«é
µçŽ å
ç«æž¬å®æ³ã«ãã
ãŠã¯ãæšèæäœãŸãã¯æšèæåã®ãã«ãªãã·ããŒ
ãŒæŽ»æ§ã枬å®ããããšã«ãããçäœçç掻æ§ç©è³ª
ãããã¯çäœæåãäŸãã°ãã€ã³ã¹ãªã³ãç²ç¶è
º
åºæ¿ãã«ã¢ã³çã®æé·ãã«ã¢ã³ãαâããšããã
ãã€ã³ãã«ã«ããããšã³ããªãªããã¯ãã¢ã³ãã²
ã³ãå
ç«ã°ãããªã³ïŒ¥ïŒIgEïŒãããšãªãã³ãβ2â
ãã€ã¯ãã°ãããªã³çã®æ¥µåŸ®éã®è¡æž
ã¿ã³ãã¯è³ª
ã®æž¬å®ãè¡ãªãããšãã§ããã
ãšããã§ãéé
žåç©è³ªãç¹ã«éé
žåæ°ŽçŽ ã®å®é
æ³ãšããŠã¯çºè²å€ãšããŠãïœâãžã¢ãã·ãžã³ãçš
ããæ¹æ³ãŸãã¯ïŒâã¢ããã¢ã³ãããªã³ãšããšã
ãŒã«ãçšããæ¹æ³çãç¥ãããŠããïŒæ€æ»ãšæè¡
Vol.9ãNo.11ãâ867ã871ïŒ1981ïŒïŒãããããªã
ããåè
ã¯éå
æ§ç©è³ªãäŸãã°ãã¢ã«ãããé¡ãš
åå¿ããæ§è³ªãããããããã®åå¿ãéé
žåæ°ŽçŽ
ã«ç¹ç°çã§ãªãæ¬ ç¹ãæã€ãŠããããŸããåŸè
ã¯ãæ床ãååã§ãªããããè¡æž
çã®è²Žéãªè©Šæ
ãå€éå¿
èŠãšãªãããŸãããããããã«ã枬å®æ
ã«ãå
±åç©è³ªã®åœ±é¿ãåããããæ¬ ç¹ãæããŠã
ãã
äžæ¹ãéé
žåé
µçŽ ã®æŽ»æ§æž¬å®æ¹æ³ãšããŠã¯ãé
é
žåç©è³ªãåºè³ªãšããïœâãžã¢ãã·ãžã³ãããã¯
ããã¬ããŒã«ããã³ããšãã¬ã³ãžã¢ãã³èªå°äœã
çºè²å€ãšããŠçšããæ¹æ³ãç¥ããŠãããããããª
ãããïœâãžã¢ãã·ãžã³ããã¡ããæ¹æ³ã¯åè¿°ã®
ããšããåå¿ãéç¹ç°çã§ããããŸããããã¬ã
ãŒã«ã䜿çšãã枬å®æ¹æ³ã¯é
µçŽ åå¿åŸã®åè²çæ
ç©è³ªã®çæã®ãããããšãã«ã»ãšãŒãã«ã䜿çš
ããæœåºæäœããããããããã«ã粟床ãèŠæ±ã
ããçã®äžäŸ¿ããæããããŸãããããããã«ã
å®çšæ§ã«ãšãŒãããããšãã¬ã³ãžã¢ãã³èªå°äœã
äŸãã°ãïœâããšãã¬ã³ãžã¢ãã³ã䜿çšãã枬å®
æ³ã¯äžè¬ã«è¯ã䜿çšãããæ床ã®ç¹ã§ã¯ç³ãåã
ãªããããããïœâããšãã¬ã³ãžã¢ãã³ã¯å
é
žå
ãåãããããäžå®å®ã§éç¹ç°çåå¿ã«ããçºè²
ãã¿ãããããã«åæ±ãã«ã¯çŽ°å¿ã®æ³šæãå¿
èŠã§
ãããããããã«ãå
é
žåçã®éç¹ç°çåå¿ãã
ãããããã«ãææã§åæ±ã€ããããå¿
èŠããã
çã®äžäŸ¿ããæããŠããã
åŸæ¥ããçºè²å€ã®å®å®åæ³ãšããŠã¯ãé®å
ãã
æ¹æ³ãEDTAãæ·»å ããæ¹æ³çãçšããããã
ãã©ããå¿
ããããå¹æçã§æå©ãªæ¹æ³ãšã¯èšã
ãªããããã«ãé
žåçºè²ç³»ã«éå
æ§ç©è³ªãæ·»å ã
ããšçºè²åå¿ã劚害ããããšã¯å
¬ç¥ã®äºå®ã§ãã
ïŒæ€æ»ãšæè¡Vol.9ãNo.11ãâ867ã871ïŒâ²81ïŒïŒã
æ¬çºæè
ãã¯æ°Žæº¶æ¶²äžã§ã®é
žååå¿ã®æ€èšãé²
ããŠããéçšã§ãé
žååå¿ã®ç¹æ®æ§ïŒäŸãã°é
žçŽ
ã©ãžã«ã«ã®åå¿æ§ãé
žçŽ ã€ãªã³ã®åå¿æ§ãããã«
ã¯ã溶åããååç¶é
žçŽ ã®åå¿æ§çïŒãéææ€èš
ããããšã«ãããïœâããšãã¬ã³ãžã¢ãã³ã®é
žå
çºè²ç³»ã«ãããŠãä¿®é
žåã¯ãã®å¡©ãéé
žåé
µçŽ ã
äŸãã°ããã«ãªãã·ããŒãŒã«ããé
žååå¿ãé»å®³
ããªãã°ããããå®å®ãªåè²ãéæã§ããããšã
ãããæ¬çºæãå®æããã
ããªãã¡ãæ¬çºæã¯ããšãã¬ã³ãžã¢ãã³ãŸãã¯
ãã®èªå°äœãä¿®é
žãŸãã¯ãã®å¡©ããã³æ°Žæº¶æ§é«å
åååç©ãå«ãããšãç¹åŸŽãšããå®å®ãªéé
žåç©
質ãŸãã¯éé
žåé
µçŽ 掻æ§æž¬å®è©Šè¬çšçºè²å€çµæç©
ã§ããã
ä¿®é
žãŸãã¯ãã®å¡©ãšããŠã¯èé
žããã³ãã®ãã
ãªãŠã ãã«ãªãŠã ããªããŠã çã®ã¢ã«ã«ãªéå±
å¡©ããã°ãã·ãŠã ãã«ã«ã·ãŠã çã®ã¢ã«ã«ãªåé¡
éå±å¡©ãããã«ã¯ãããã®ã¢ã³ã¢ããŠã å¡©çãæ
ããããšãã§ããã
ãŸããæ¬çºæã«äœ¿çšãããããšãã¬ã³ãžã¢ãã³
ãŸãã¯ãã®èªå°äœãšã¯ãäŸãã°ãooâããšãã¬
ã³ãžã¢ãã³ãïœâããšãã¬ã³ãžã¢ãã³ãïœâããš
ãã¬ã³ãžã¢ãã³ãïœâããšãã¬ã³ãžã¢ãã³ãïœâ
ããšãã¬ã³ãžã¢ãã³ããã³ãããã®ç¡«é
žå¡©ãå¡©é
ž
å¡©ãŸãã¯èé
žå¡©ãããã«ãïŒâã¢ããâïŒïŒ®â
ãžã¡ãã«ã¢ããªã³ãïŒâã¢ããâïŒïŒ®âãžãšã
ã«ã¢ããªã³ãïŒâã¢ããâïŒïŒ®âãžãããã«ã¢
ããªã³ãïŒâã¢ãããã«ã€ãžã³ãïŒâã¢ããâ
ïŒïŒ®âãžãšãã«âïœâãã«ã€ãžã³ãïŒâã¢ãã
ââãšãã«ââβâããããã·ãšãã«âïœâ
ãã«ã€ãžã³çãæããããšãã§ããã
éé
žåé
µçŽ ãšããŠã¯äŸãã°ããã«ãªãã·ããŒ
ãŒãã©ã¯ããã«ãªãã·ããŒãŒãããã¯ããŒã ãã«
ãªãã·ããŒãŒçãããã
ããã«ã氎溶æ§é«ååç©è³ªãšããŠã¯ããªãšãã¬
ã³ã°ãªã³ãŒã«ïŒä»¥äžPEGãšç¥ãïŒãããç³ãããª
ããã«ã¢ã«ã³ãŒã«çã䜿çšãããã
æ¬çºæã®çºè²å€çµæç©ã«ãããä¿®é
žãŸãã¯ãã®
å¡©ã¯éåžž0.1ïœïŒã5Mã奜ãŸããã¯ïŒïœïŒã1M
ã§ãããããšãã¬ã³ãžã¢ãã³ãŸãã¯ãã®èªå°äœã¯
ïŒïœïŒã100ïœïŒã§ãããããã«ã氎溶æ§é«åå
ç©è³ªã¯ã氎溶液ã«å¯ŸããŠ0.001ã10ééïŒ
ã奜ãŸ
ããã¯ïŒãïŒééïŒ
å«ãŸããããŸããPHã¯ïŒãïŒ
ã®ç¯å²ã§ããããšã奜ãŸããã
æ¬çºæã®çºè²å€çµæç©ã«ã¯ãéé
žåç©è³ªãŸãã¯
éé
žåé
µçŽ ãæ°ŽãŸãã¯ç·©è¡æ¶²ãå«ãŸããŠããŠãã
ããããã«å¿
èŠã«ããä»ã®å®å®å€ãé²è
å€çãå«
ãŸããŠããŠãããã
æ¬çºæã®çºè²å€çµæç©ããã³éé
žåé
µçŽ ã䜿çš
ãã枬å®äŸãšããŠã¯ãäŸãã°ããããŠç³ãå°¿é
žã
ã³ã¬ã¹ãããŒã«ãã¢ãã¢ãã³çã®äœæ¶²æåãã€ã³
ã¹ãªã³ãç²ç¶è
ºåºæ¿ãã«ã¢ã³çã®æé·ãã«ã¢ã³ã
αâããšããããã€ã³ãã«ã«ããã»ãšã³ããªãªã
ãã¯ã»ã¢ã³ãã²ã³ãå
ç«ã°ãããªã³ïŒ¥ïŒIgEïŒãã
ãšãªãã³ãβ2âãã€ã¯ãã°ãããªã³çã®æ¥µåŸ®éã®
è¡æž
ã¿ã³ãã¯è³ªçãããããããæ¬çºæã®çºè²å€
çµæç©ããã³éé
žåæ°ŽçŽ ã䜿çšãã枬å®äŸãšããŠ
ã¯ãäŸãã°ã€ã³ã¹ãªã³ãç²ç¶è
ºåºæ¿ãã«ã¢ã³çã®
æé·ãã«ã¢ã³ãαâããšããããã€ã³ãã«ã«ã
ãã»ãšã³ããªãªããã¯ã»ã¢ã³ãã²ã³ãå
ç«ã°ãã
ãªã³ïŒ¥ïŒIgEïŒãããšãªãã³ãβ2âãã€ã¯ãã°ãã
ãªã³çã®æ¥µåŸ®éã®è¡æž
ã¿ã³ãã¯è³ªçããããã
ããéé
žåæ°ŽçŽ ãŸãã¯ãã«ãªãã·ããŒãŒã®æŽ»æ§ã
枬å®ããã«éããŠã¯ä¿®é
žãŸãã¯ãã®å¡©ãéåžžã
0.1ïœïŒã5Mã奜ãŸããã¯ïŒïœïŒã1Mãããšã
ã¬ã³ãžã¢ãã³èªå°äœãïŒïœïŒã100ïœïŒãããã«
ã¯ã氎溶æ§é«ååç©è³ªãäŸãã°PEG+4000ãïŒã
ïŒééïŒ
å«ãç·©è¡æ¶²ããã³ãã«ãªãã·ããŒãŒãä»»
æã®é åºã«ãŸãã¯ãåæã«ãè©Šæã«æ·»å ããã
PHã¯ïŒãïŒã®ç¯å²ã®ä»»æã®PHã§ãããïŒã60
âã奜ãŸããã¯ïŒã40âã®åå¿æž©åºŠã§ææãŸãã¯
ææã§é
µçŽ åå¿ãè¡ãªããããšãçæããéé
žå
æ°ŽçŽ éãããã¯ååšããŠãããã«ãªãã·ããŒãŒé
ã«å¿ããŠåè²ç©è³ªãçæãããçæããåè²ç©è³ª
ã®åžå極倧å€ã®æ³¢é·ã«ãããåžå
床ã枬å®ããã
äžæ¹ãæ¿åºŠæ¢ç¥ã®éé
žåæ°ŽçŽ ãŸãã¯ãã«ãªãã·ã
ãŒãŒã®æŽ»æ§å€ãåæ§ã«åå¿ãããŠæ€éç·ãäœæ
ãããã®æ€éç·ãšå¯Ÿæ¯ããŠè©Šæäžã®éé
žåæ°ŽçŽ ãŸ
ãã¯ãã«ãªãã·ããŒãŒæŽ»æ§ã枬å®ããã
é
µçŽ æšèæäœãŸãã¯é
µçŽ æšèæåãçšããæ¹æ³
ã«ãããŠã¯ãæ¿åºŠæ¢ç¥ã®æåéãŸãã¯æäœéãçš
ããŠäœæããæ€éç·ãšå¯Ÿæ¯ããŠè©Šæäžã®æåãŸã
ã¯æäœãç®åºããããšãã§ããã
æ¬çºæã§ã¯åè²åå¿ã¯ææã«ãããŠããããã«
ã¯ææã«ãããŠãåæ±ãããšãã§ããéç¹ç°çå
å¿ãæå°éã«ããããŠãæ床ãã枬å®ããããšã
ã§ããã
æ¬çºæã®çºè²å€çµæç©ã«ã¯ããšãã¬ã³ãžã¢ãã³
ãŸãã¯ãã®èªå°äœãä¿®é
žãŸãã¯ãã®å¡©ããã³æ°Žæº¶
æ§é«ååç©è³ªã®ã»ãã«å¿
èŠã«ããéé
žåé
µçŽ ãå«
ãŸããããããã«ãç·©è¡æ¶²ãæšæºæ¶²çãé垞䜿çš
ãããè©Šè¬ãå«ãããšãã§ããã
æ¬çºæã®çºè²å€çµæç©ã¯ä¿®é
žãŸãã¯ãã®å¡©ãå«
ãããšã«ãããå
ã«å¯Ÿããå®å®æ§ãæ¹è¯ãããé
ç¹ç°çåå¿ãããããããšãå¯èœãšãªãã
ããã«ã¯ã氎溶æ§é«ååç©è³ªãå«ããããšã«ã
ããçºè²å€çµæç©ã®åæ±ããããã容æãšãªãã
ããªãã¡ã氎溶æ§é«ååç©è³ªããªããŠããçºè²å€
çµæç©ã¯åçµä¹Ÿç¥ã§ãããã氎溶æ§é«ååç©è³ªã
æ·»å ããããšã«ãããæ¯åã«å¯Ÿãã圢ç¶å®å®æ§ã
倧å¹
ã«æ¹è¯ãããã
ããã«æ¬çºæã®çºè²å€çµæç©ãçšããŠãéé
žå
é
µçŽ ããã³éé
žåæ°ŽçŽ ã枬å®ããã«åœããä¿®é
žãŸ
ãã¯ãã®å¡©ããã³ã氎溶æ§é«ååç©è³ªã¯é
µçŽ åå¿
ãé»å®³ããªãç¹åŸŽãæããã
ãŸãæ¬çºæã®çºè²å€çµæç©ã¯åè²åŸã®çµæå€å
ã«ãããŠãåªããã
次ã«ãæ¬çºæãå®æœäŸã«ããããã«ãå
·äœçã«
説æããããæ¬çºæã¯ãããã«ããéå®ãããã
ã®ã§ã¯ãªãã
å®æœäŸïŒ éç¹ç°çåå¿ã®æ€èš
ïœâããšãã¬ã³ãžã¢ãã³ã»ïŒå¡©é
žå¡©ã0.02ïŒ
ã®
éé
žåæ°ŽçŽ ãå«ãããé
žâã¯ãšã³é
žç·©è¡æ¶²ïŒPH
5.7ïŒã«ã0.3ïŒ
ã«ãªãããã«å ããããã«ã
PEG+4000ãïŒïŒ
ã«ãªãããã«å ãã溶解ããã
ããã«ãåçš®ææ©éå
å€ãæ·»å å€ãšããŠå ãã溶
解åŸãè©Šéšç®¡ïŒ12mmÏÃ7.5cmïŒã«0.5mlãã€å泚
ããçºè²æ¶²ãšãªãããåçš®æ¡ä»¶äžã«æŸçœ®åŸã1N
âç¡«é
žãïŒmlæ·»å ããåŸã492nmã§ã®åžå
床ã枬
å®ããéç¹ç°çåå¿ãè©äŸ¡ããã
ãã®çµæãè¡šâïŒã«ç€ºãã
The present invention relates to a stable coloring agent composition for a reagent for measuring peroxidant or peroxidase activity, and more specifically to a stable coloring agent composition for use in a measurement system based on oxidative color development using a peroxidant or peroxidase and a coloring agent. Concerning the law. The measurement of peroxides, particularly hydrogen peroxide, has recently become increasingly important in the field of clinical testing. Hydrogen peroxide is produced by an enzymatic reaction between body fluid components such as glucose, uric acid, cholesterol, and monoamines with glucose oxidase, uricase, cholesterol oxidase, and monoamine oxidase. By quantifying the generated hydrogen peroxide using a coloring agent and peroxidase, the content of each body fluid component can be determined. Furthermore, the measurement of peroxidase activity is becoming increasingly important in enzyme immunoassay using peroxidase as a labeling substance. Generally, in enzyme immunoassay, by measuring the peroxidase activity of labeled antibodies or labeled antigens, biologically active substances or biological components, such as insulin, growth hormones such as thyroid-stimulating hormone, α-fetoprotein, carcinolin, etc. , embryonic, antigen, immunoglobulin E (IgE), ferritin, β 2 â
It is possible to measure extremely small amounts of serum proteins such as microglobulin. By the way, as a method for quantifying peroxide substances, particularly hydrogen peroxide, methods using o-dianisidine or methods using 4-aminoantipyrine and phenol as coloring agents are known (Inspection and Technology).
Vol.9, No.11, P-867-871 (1981)). However, since the former has the property of reacting with reducing substances such as aldehydes, it has the disadvantage that its reaction is not specific to hydrogen peroxide. Furthermore, since the latter method does not have sufficient sensitivity, it requires a large amount of valuable samples such as serum. Moreover, it also has the disadvantage that it is easily influenced by coexisting substances during measurement. On the other hand, as a method for measuring peroxidase activity, a method is known in which a peroxide substance is used as a substrate and o-dianisidine or pyrogallol and a phenylenediamine derivative are used as coloring agents. However, as described above, the reaction using o-dianisidine is nonspecific. Furthermore, the measurement method using pyrogallol uses ethyl ether, which tends to produce colored substances after enzymatic reaction, and has the inconvenience of requiring precision because the extraction operation is repeated. Also, because of that,
Not very practical. phenylenediamine derivative,
For example, a measurement method using o-phenylenediamine is commonly used and has satisfactory sensitivity. However, o-phenylenediamine is susceptible to photo-oxidation, is unstable, and develops color due to non-specific reactions, so it must be handled with great care. Therefore, it has some inconveniences, such as the need to handle it in a dark place in order to suppress non-specific reactions such as photo-oxidation. Conventionally, methods for stabilizing color formers include blocking light, adding EDTA, etc., but these methods cannot necessarily be said to be effective or advantageous. Furthermore, it is a well-known fact that adding a reducing substance to an oxidative coloring system interferes with the coloring reaction (Inspection and Technology Vol. 9, No. 11, P-867-871 ('81)). In the process of investigating oxidation reactions in aqueous solutions, the present inventors discovered the specificities of oxidation reactions (e.g., the reactivity of oxygen radicals, the reactivity of oxygen ions, and the reactivity of dissolved molecular oxygen). etc.), we found that in the oxidative coloring system of o-phenylenediamine, oxalic acid or its salt is a peroxidase,
For example, it was found that not only did the oxidation reaction by peroxidase not be inhibited, but also stable coloration could be achieved, and the present invention was completed. That is, the present invention is a stable coloring agent composition for a peroxidant or peroxidase activity measuring reagent, which is characterized by containing phenylenediamine or a derivative thereof, oxalic acid or a salt thereof, and a water-soluble polymer compound. Examples of oxalic acid or its salts include oxalic acid and its alkali metal salts such as sodium, potassium, and lithium, alkaline earth metal salts such as magnesium and calcium, and ammonium salts thereof. Further, the phenylene diamine or its derivative used in the present invention includes, for example, oo-phenylene diamine, m-phenylene diamine, p-phenylene diamine, m-phenylene diamine, p-
phenylenediamines and their sulfates, hydrochlorides or oxalates, as well as 4-amino-N,N-
Dimethylaniline, 4-amino-N,N-diethylaniline, 4-amino-N,N-dipropylaniline, 4-aminotoluidine, 4-amino-
N,N-diethyl-m-toluidine, 4-amino-N-ethyl-N-β-hydroxyethyl-m-
Examples include toluidine. Examples of peroxidases include peroxidase, lactoperoxidase, and cytochrome peroxidase. Further, as the water-soluble polymer substance, polyethylene glycol (hereinafter abbreviated as PEG), sucrose, polyvinyl alcohol, etc. can be used. In the color former composition of the present invention, oxalic acid or its salt is usually 0.1mM to 5M, preferably 1mM to 1M.
and phenylenediamine or its derivative is 1mM to 100mM. Further, the water-soluble polymer substance is contained in an amount of 0.001 to 10% by weight, preferably 1 to 2% by weight, based on the aqueous solution. Also, the pH is 4-9
It is preferable that it is in the range of . The color former composition of the present invention may contain a peroxidant or a peroxidase, water, or a buffer. Furthermore, other stabilizers, preservatives, etc. may be included if necessary. Examples of measurements using the color former composition and peroxidase of the present invention include, for example, glucose, uric acid,
Body fluid components such as cholesterol and monoamines, growth hormones such as insulin and thyroid stimulating hormone,
Examples include minute amounts of serum proteins such as α-fetoprotein, carcinogenic antigen, immunoglobulin E (IgE), ferritin, and β 2 -microglobulin. Measurement examples using the color former composition of the present invention and hydrogen peroxide include, for example, insulin, growth hormones such as thyroid stimulating hormone, α-phetoprotein, carcinoid embryonic antigen, immunoglobulin E (IgE), Examples include trace amounts of serum proteins such as ferritin and β 2 -microglobulin. When measuring hydrogen peroxide or peroxidase activity, oxalic acid or its salt is usually used.
0.1mM to 5M, preferably 1mM to 1M, a phenylenediamine derivative of 1mM to 100mM, and further a water-soluble polymeric substance, such as PEG + 4000, of 1 to 1M.
Buffer and peroxidase containing 2% by weight are added to the sample in any order or simultaneously. PH is any PH in the range of 4-9. 2ïœ60
When the enzymatic reaction is carried out in the dark or in the light at a reaction temperature of 2 to 40 DEG C., a colored substance is produced depending on the amount of hydrogen peroxide produced or the amount of peroxidase present. The absorbance at the wavelength of the maximum absorption value of the produced colored substance is measured.
On the other hand, a calibration curve is created by similarly reacting the activity values of hydrogen peroxide or peroxidase with known concentrations, and the hydrogen peroxide or peroxidase activity in the sample is measured by comparing with this calibration curve. In a method using an enzyme-labeled antibody or enzyme-labeled antigen, the amount of antigen or antibody in a sample can be calculated by comparing it with a standard curve prepared using an amount of antigen or antibody whose concentration is known. In the present invention, the color reaction can be handled both in the dark and in the light, and can be measured with high sensitivity while minimizing non-specific reactions. In addition to phenylenediamine or a derivative thereof, oxalic acid or a salt thereof, and a water-soluble polymer substance, the color former composition of the present invention contains peroxidase if necessary, and further contains buffer solutions, standard solutions, etc. It can include the reagents used. By containing oxalic acid or a salt thereof, the color former composition of the present invention has improved stability against light and can suppress non-specific reactions. Furthermore, by including a water-soluble polymeric substance, the color former composition becomes easier to handle.
That is, although the color former composition can be freeze-dried without a water-soluble polymeric substance, the shape stability against vibration is significantly improved by adding a water-soluble polymeric substance. Furthermore, when measuring peroxidase and hydrogen peroxide using the color former composition of the present invention, oxalic acid or its salt and the water-soluble polymer substance have the characteristic that they do not inhibit the enzymatic reaction. Furthermore, the color former composition of the present invention is also excellent in changes over time after coloring. Next, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited thereto. Example 1 Examination of non-specific reactions O-phenylenediamine dihydrochloride was added to a phosphate-citrate buffer (PH
5.7), add it to 0.3%, and further,
PEG + 4000 was added to 1% and dissolved.
Furthermore, various organic reducing agents were added as additives, and after dissolving, 0.5 ml each was dispensed into test tubes (12 mmÏ x 7.5 cm) to obtain a coloring solution. 1N after being left under various conditions
- After adding 2 ml of sulfuric acid, the absorbance at 492 nm was measured to evaluate non-specific reactions. The results are shown in Table-1.
ãè¡šã
è¡šâïŒãããPEG+4000ãæ·»å ããç³»ã«ãã
ãŠãç¡æ·»å ã«æ¯èŒããŠä¿®é
žãŸãã¯ãã®å¡©ãã¢ã¹ã³
ã«ãã³é
žãããããã·ã«ã»ã¢ãã³ã»ç¡«é
žå¡©ãã°ã«
ã³ãŒã¹çã®éå
æ§ç©è³ªãéç¹ç°çåå¿ããããã
ããšãããã€ãã
å®æœäŸïŒ åçš®éå
æ§ç©è³ªæ·»å ç³»ã«ããããã«ãª
ãã·ããŒãŒã«ããé
µçŽ åå¿ã®æ€èš
ïœâããšãã¬ã³ãžã¢ãã³ã»ïŒå¡©é
žå¡©ã0.02ïŒ
ã®
éé
žåæ°ŽçŽ ãå«ããªã³é
žâã¯ãšã³é
žç·©è¡æ¶²ïŒPH
5.7ïŒã«0.3ïŒ
ã«ãªãããã«å ããããã«ã
PEG+4000ãïŒïŒ
ã«ãªãããã«å ãã溶解ããã
ããã«ãåçš®æ¿åºŠã®éå
æ§ç©è³ªãå ã溶解åŸãè©Š
éšç®¡ïŒ12mmÏÃ7.5cmïŒã«0.5mlãã€å泚ããçºè²
液ãäœæããã次ã«ããã«ãªãã·ããŒãŒã0.15ïœ
ïŒmlã«ãªãããã«0.1ïŒ
BSA氎溶液ã§æº¶è§£ãã
é
µçŽ 溶液ãšããããã®é
µçŽ 溶液ãäžèšã«ãŠæºåã
ãçºè²æ¶²ã«50ÎŒãå ãã宀枩ã«ãŠ30åéãææ
ã§åå¿ãããåå¿çµäºåŸã1Nã»ç¡«é
žãïŒmlæ·»å
ããåå¿åæ¢åŸã492nmã§ã®åžå
床ã枬å®ããå
çš®éå
æ§ç©è³ªå
±åäžã«ãããé
µçŽ åå¿ã®é»å®³äœçš
ãæ€èšããã
ãã®çµæãè¡šâïŒã«ç€ºãã[Table] Table 1 shows that in the system with PEG + 4000 added, reducing substances such as oxalic acid or its salts, ascorbic acid, hydroxyl/amine/sulfate, glucose, etc. reacted nonspecifically compared to the system without addition. I found out that I can control it. Example 2 Examination of enzymatic reactions by peroxidase in various reducing substance addition systems
5.7) to be 0.3%, and further,
PEG + 4000 was added to 1% and dissolved.
Furthermore, various concentrations of reducing substances were added and dissolved, and 0.5 ml each was dispensed into test tubes (12 mmÏ x 7.5 cm) to prepare a coloring solution. Next, add peroxidase to 0.15 m
Dissolve in 0.1% BSA aqueous solution at U/ml,
It was made into an enzyme solution. 50Ό of this enzyme solution was added to the coloring solution prepared above and reacted in the light at room temperature for 30 minutes. After the reaction was completed, 2 ml of 1N sulfuric acid was added to stop the reaction, and the absorbance at 492 nm was measured to examine the inhibitory effect on enzyme reactions in the presence of various reducing substances. The results are shown in Table-2.
ãè¡šã
â» âã¯æº¶è§£äžèœã®ããã枬å®ããªãã€ãã
è¡šâïŒããæãããªããã«ãä¿®é
žãŸãã¯ãã®å¡©
ã¯é
µçŽ åå¿ç³»ã«æ·»å ãããŠããå
šãé
µçŽ åå¿ãé»
害ããªãããšãããã€ããã¢ã¹ã³ã«ãã³é
žçã¯æ¿
床ã«å€§ããäŸåããããã©ããäœæ¿åºŠã®æ·»å åã§
ã¯è¥å¹²ã®çºè²ãã¿ããããã®ã®ãé
µçŽ åå¿ãèã
ãé»å®³ããã
å®æœäŸïŒ çºè²å€çµæç©ã®åçµä¹Ÿç¥
è¡šâïŒã«ç€ºããããªçºè²å€çµæç©ãåçµä¹Ÿç¥ã
ãããªããåçµä¹Ÿç¥ã¯30mlã®ãã€è²ãã€ã€ã«ãã³
ã䜿çšããïŒmlã¥ã€å泚åŸããã¿ããã«åžžæ³ã«ã
ãåçµä¹Ÿç¥ããããªããåçµä¹Ÿç¥çµäºåŸçªçŽ 眮æ
ãããè¡šâïŒäžã®è²èª¿ã¯ç®èŠèŠ³å¯ãã圢ç¶å®å®æ§
ã¯ãã€ã€ã«ãã³ãå転ãããç²æ«ã®ã§ãããã§ã
ãã®ããããããã衚瀺ããããªããåçµä¹Ÿç¥å
ã®æº¶æ¶²èª¿æŽæãèžçæ°ŽãŸãã¯ã0.01Mâã¯ãšã³é
ž
âããé
žç·©è¡æ¶²ïŒPHïŒ5.0ïŒã䜿çšããã[Table] * - was not measured because it could not be dissolved.
As is clear from Table 2, it was found that even when oxalic acid or its salt was added to the enzyme reaction system, it did not inhibit the enzyme reaction at all. Ascorbic acid and the like greatly depend on the concentration, but at low concentrations, some color development was observed, but the enzyme reaction was significantly inhibited. Example 3 Freeze-drying of color former composition A color former composition shown in Table 3 was freeze-dried. For freeze-drying, a 30-ml colored vial was used, and after dispensing 6 ml each, the solution was immediately freeze-dried using a conventional method. Note that after the freeze-drying was completed, the atmosphere was replaced with nitrogen. The color tone in Table 3 was visually observed, the shape stability was determined by rotating the vial, and the ease with which the powder came out.
It displayed its fragility. In addition, when preparing the solution before freeze-drying, distilled water or 0.01M citric acid-phosphate buffer (PH: 5.0) was used.
ãè¡šããtableã
ãè¡šã
泚âïŒ åœ¢æ
å®å®æ§ã¯ããŒã©ãŒäžã§ããã€ã€ã«ã
ã³ã暪ã«ããŠã埮æ¯åãäžããªããå転ã
ããæåã«ç²æ«ãåé¢ããŠãããŸã§ã®å転
æ°ãæ±ãã圢ç¶ã®ããããããã衚瀺ã
ãã
枬å®äŸïŒ åçµä¹Ÿç¥åã®ä¿åå®å®æ§è©Šéš
å®æœäŸïŒã§äœæããåçµä¹Ÿç¥åã®ïŒâã§ã®ä¿å
å®å®æ§è©Šéšãå®æœãããããªãã¡ãïŒâã«æå®æ
éä¿ååŸããã€ã€ã«ãã³åœãã0.02ïŒ
ã®éé
žåæ°Ž
çŽ ãå«ãã¯ãšã³é
žâãªã³é
žç·©è¡æ¶²ïŒPHïŒ5.7ïŒ20
mlãå ããå®å
šæº¶è§£ïŒäœããNo.ïŒã¯40mlãå ã溶
解ïŒããã溶解åŸãè©Šéšç®¡ïŒ12mmÏÃ7.5cmïŒã«
0.5mlã¥ã€å泚ããçºè²æ¶²ãšãªãã宀枩ãææã®
æ¡ä»¶äžã«ïŒæéæŸçœ®åŸãïŒèŠå®ã®ç¡«é
žãïŒmlæ·»å
ããåŸã492nmã§ã®åžå
床ã枬å®ãããã©ã³ã¯çº
è²ã®çšåºŠããä¿åå®å®æ§ãè©äŸ¡ããããªãã察ç
§
ãšããŠãå®éšNo.ïŒãšåäžçµæãšãªãããã«ãïœâ
ããšãã¬ã³ã»ãžã¢ãã³ã»ïŒå¡©é
žå¡©ïŒmgïŒmlãèé
ž
ã¢ã³ã¢ããŠã 3.5ïœïŒãPEG+4000 0.5mgïŒmlã®æ¿
床ã«ããããã秀éããã¯ãšã³é
žâãªã³é
žç·©è¡æ¶²
ïŒPHïŒ5.7ïŒã«æº¶è§£ããããã®çµæã¯è¡šâïŒã«ç€ºã
ãŠãããè¡šâïŒããæãããªããã«ãç¡æ·»å ç³»ã«
æ¯èŒããŠãææ©éå
å€æ·»å ç³»ã¯ãã©ã³ã¯çºè²ãå°
ããããŸããé·æä¿ååŸã«ãããŠãããã©ã³ã¯çº
è²ã¯ã»ãšãã©äžæããªãã€ãã[Table] Note 1: Shape stability is determined by rotating the vial horizontally on a roller while applying slight vibrations, and determining the number of revolutions until the powder first separates, which indicates the fragility of the shape. did. Measurement Example 1 Storage Stability Test of Freeze-Dried Product A storage stability test of the freeze-dried product prepared in Example 3 at 4°C was conducted. That is, after storing at 4°C for a specified period of time, citric acid-phosphate buffer (PH: 5.7) containing 0.02% hydrogen peroxide was added per vial.
ml was added and completely dissolved (however, No. 5 was dissolved by adding 40 ml). After dissolving, transfer to test tube (12mmÏ x 7.5cm)
Dispense 0.5 ml each to make a coloring solution, leave it at room temperature in a bright place for 1 hour, add 2 ml of 1N sulfuric acid, measure the absorbance at 492 nm, and check the degree of blank color development to determine storage stability. The gender was evaluated. As a control, o-
Phenylene diamine dihydrochloride 3 mg/ml, ammonium oxalate 3.5 mM, and PEG + 4000 0.5 mg/ml were each weighed and dissolved in citric acid-phosphate buffer (PH: 5.7). The results are shown in Table-4. As is clear from Table 4, compared to the additive-free system, the organic reducing agent-added system showed less blank color development, and the blank color development hardly increased even after long-term storage.
ãè¡šã
枬å®äŸïŒ ã€ã³ã¹ãªã³åæè©Šéš
å®æœäŸïŒïŒïŒã®çµæãå©çšããŠããµã³ãã€ãã
æ³EIAã«ããã€ã³ã¹ãªã³ãåæããã
ã€ã³ã¹ãªã³æž¬å®çšäžæº¶åè©Šéšã®è£œé
æãã¿ã€ã³ã¹ãªã³æè¡æž
ïŒã¢ã«ã¢ããïŒãã45
ïŒ
飜åç¡«å®ã«ãŠåç»åŸãDEAEâã»ãã¢ãâã¹ã«
ã©ã ã«ãŠç²Ÿè£œããæäœç»åãåŸãããã®æäœç»å
ã0.01Mãªã³é
žç·©è¡æ¶²ïŒPHïŒ7.2ïŒ0.15MNaClå«
æïŒãçšããæ¿åºŠãïŒmlåœãïŒmgãšãªãããã«åž
éãã溶液50mlã«ãååæŽæµããç²é¢åããªã¹ã
ã¬ã³ããŒã«400åã浞挬ãã宀枩ã§ïŒæéé眮ã
ãããã®åŸãããªã¹ãã¬ã³ããŒã«ã浞挬液ããå
é¢ããçè¡æž
ã¢ã«ããã³ãïŒïŒ
å«æãã0.01Mãª
ã³é
žç·©è¡æ¶²ïŒPHïŒ7.2ïŒ0.15MNaClå«æïŒãçšã
ãŠïŒåæŽæµããåŸãåäžç·©è¡æ¶²äžã«ä¿åããã
ãã«ãªãã·ããŒãŒæšèæäœã®èª¿è£œ
é
µçŽ ãšããŠ10mgã®ãã«ãªãã·ããŒãŒïŒè¥¿æŽã¯ãµ
ãç±æ¥ïŒã䜿çšããéããçŽ é
žæ¶æ©æ³ã«ãã€ãŠïŒ
mgã®æãã¿ã€ã³ã¹ãªã³æäœã«ãã«ãªãã·ããŒãŒã
çµåãããã»ãã¢ããã¯ã¹ïŒ§â200ã«ããã²ã«
éã«ãã€ãŠç²Ÿè£œåŸãã³ããžãªã³ããã¯ã§æ¿çž®ãã
ãã«ãªãã·ããŒãŒæšèæäœãšãããæäœãžã®ãã«
ãªãã·ããŒãŒã®çµåæ¹æ³ã¯ïŒ°ããã«ãçïŒã¶ã»ãž
ã€ãŒãã«ã»ãªãã»ãã¹ãã±ãã¹ããªãŒã»ã¢ã³ãã»
ãµã€ãã±ãã¹ããªãŒã第22å·»ã第12å·ãâ1084
ã1091ïŒ1974幎ïŒã«èšèŒãããŠãããåŸãããã
ã«ãªãã·ããŒãŒæšèæäœã¯äœ¿çšçŽåã«ïŒïŒ
çè¡æž
ã¢ã«ããã³ãå«æãã0.01Mãªã³é
žç·©è¡æ¶²ïŒPHïŒ
7.2ïŒ0.15M NaClå«æïŒã§2000åéè¿ãŸã§åžéã
䜿çšããã
ã€ã³ã¹ãªã³ã®æž¬å®æ¹æ³
è©Šéšç®¡ïŒ12mmÏÃ7.5cmïŒã«ç·©è¡æ¶²âïŒ0.5ïŒ
çè¡æž
ã¢ã«ããã³å«æ0.01ãªã³é
žç·©è¡æ¶²ïŒPHïŒ
7.2ïŒ0.15M NaClå«æïŒïŒ0.4mlããã³WHOã®ã
ã³ããŒ66ïŒ304ãåºæºã«ããŠäœæããæšæºã€ã³ã¹
ãªã³æº¶æ¶²ïŒïŒã320ÎŒUïŒmlïŒ0.1mlãæ·»å ããã
ãæ··åããŠãã枬å®äŸâïŒã®ã®é
ã§äœæããäž
溶åè©Šè¬ïŒåãå
¥ãã37âã§ïŒæéãå æž©ããã
å æž©çµäºåŸãè©Šéšç®¡å
ã®åå¿æ¶²ãåžåŒé€å»ããç·©
è¡æ¶²âã®ïŒmlãå ããŠæŽæµããããã®æäœãïŒ
åç¹°ãããããåŸã枬å®äŸâïŒã®é
ã§åŸããã«
ãªãã·ããŒãŒæšèæäœ250ÎŒãå ãã37âã§ïŒ
æéãå æž©ãããå æž©çµäºåŸãåèšãšåæ§ã«åå¿
液ãåžåŒé€å»ããïŒåæŽæµåŸãå®æœäŸïŒã§äœæã
ãåçµä¹Ÿç¥çºè²å€çµæç©ããã枬å®äŸâïŒã§ç€ºã
ãæ¹æ³ã«åŸã€ãŠäœæããçºè²æ¶²ã«ããŒã«ã®ã¿ã移
ããåçš®æ¡ä»¶äžã§é
µçŽ åå¿ãå®æœãããé
µçŽ åå¿
çµäºåŸã1Nç¡«é
žïŒmlãæ·»å ããŠåå¿ãåæ¢åŸã
èµ€ãã€è²ã®è²çŽ ã492nmã§æž¬å®ããã
é
µçŽ åå¿æ¡ä»¶ãå€ããæã®æ€éç·ã®å€åã®æ€
èš
ã®æž¬å®æ¹æ³ã«åŸã€ãŠãã€ã³ã¹ãªã³æšæºåã枬
å®ããæ€éç·ãäœæããããªããçºè²æ¶²ã¯å®æœäŸ
ïŒã§äœæããåçµä¹Ÿç¥åã䜿çšããããŸããåçµ
也ç¥åã«ã¯70ïœïŒã®èé
žã¢ã³ã¢ããŠã ãæ·»å ããŠ
åçµä¹Ÿç¥ãããã®ãšãç¡æ·»å ã§åçµä¹Ÿç¥ããçºè²
å€ã®å Žåã«ã€ããŠé
µçŽ åå¿ãè¡ãªã€ãããŸããé
µ
çŽ åå¿ã¯å®€æž©ãææãïŒæéããã³ïŒâãïŒå€æŸ
眮ã§è¡ãªããåè
ã®çµæã¯ç¬¬ïŒå³ã«ãåŸè
ã®çµæ
ã¯ç¬¬ïŒå³ã«ç€ºããŠããããããã®å³ããæãããª
ããã«ãã€ã³ã¹ãªã³äœæ¿åºŠåŽã«ãããŠãæ床ã倧
å¹
ã«æ¹è¯ããããšå
±ã«ãéç¹ç°çåå¿ããããã
ããŠããããšããããã
åè²åŸã®çµæå€åã«ã€ããŠã®æ€èš
ã®æž¬å®æ¹æ³ã«åŸã€ãŠãã€ã³ã¹ãªã³æšæºåã枬
å®ããããªããåè²å®å®æ§ã¯åçš®éå
æ§ç©è³ªã®æ·»
å ã®æç¡ã«ãã€ãŠãåè²å®å®æ§ã¯ã©ã®ããã«å€å
ãããæ€èšãããã®çµæãè¡šâïŒã«ç€ºããããŸ
ããåå¿åæ¢çŽåŸã®åžå
床ïŒ492nmïŒã100ãšã
ãæã®çµæå€åã«ãã€ãŠç€ºããŠããã[Table] Measurement Example 2 Insulin Analysis Test Utilizing the results of Examples 1 and 2, insulin was analyzed by Sand-Germany EIA. Manufacture of insolubilization test for insulin measurement 45 from anti-porcine insulin antiserum (guinea pig)
After fractionation using saturated ammonium sulfate, the antibody fraction was purified using a DEAE-Sepharose column to obtain an antibody fraction. This antibody fraction was diluted with 0.01M phosphate buffer (PH: 7.2; containing 0.15M NaCl) and 400 thoroughly washed roughened polystyrene balls were immersed in 50ml of a solution with a concentration of 1mg per ml. The mixture was left standing at room temperature for 8 hours. Thereafter, the polystyrene balls were separated from the immersion solution, washed three times with 0.01M phosphate buffer (PH: 7.2; containing 0.15M NaCl) containing 1% bovine serum albumin, and then stored in the same buffer. . Preparation of peroxidase-labeled antibody Using 10 mg of peroxidase (derived from horseradish) as the enzyme, 5
mg of anti-porcine insulin antibody was conjugated with peroxidase, purified by gel filtration using Sephadex G-200, concentrated in a collodion bag,
It was used as a peroxidase-labeled antibody. A method for attaching peroxidase to antibodies is described by P., Nakane et al.: The Journal of Histochemistry and
Cytochemistry, Volume 22, No. 12, P-1084
~1091 (1974). The obtained peroxidase-labeled antibody was added to 0.01M phosphate buffer (PH:
7.2; containing 0.15M NaCl) and diluted to approximately 2000 times before use. Insulin measurement method: Add buffer solution (0.5%) to a test tube (12mmÏ x 7.5cm)
0.01 phosphate buffer containing bovine serum albumin <PH:
7.2; Contains 0.15M NaCl>) 0.4ml and 0.1ml of standard insulin solution (5-320ΌU/ml) prepared based on WHO number 66/304, mix well, and then proceed to Measurement Example-2. One insolubilizing reagent prepared in Section 1 was added and heated at 37°C for 1 hour.
After heating, the reaction solution in the test tube was removed by suction, and 1 ml of buffer solution was added for washing. Perform this operation 3
After repeating the test several times, add 250Ό of the peroxidase-labeled antibody obtained in Measurement Example-2, and
Warmed for an hour. After heating, the reaction solution was removed by suction in the same manner as above, and after washing three times, a coloring solution was prepared from the freeze-dried coloring agent composition prepared in Example 3 according to the method shown in Measurement Example-1. The enzyme reaction was carried out under various conditions. After the enzymatic reaction is complete, add 2 ml of 1N sulfuric acid to stop the reaction,
Red and colored pigments were measured at 492 nm. A standard insulin product was measured and a calibration curve was created according to the measurement method described in ``Examination of changes in the calibration curve when enzyme reaction conditions are changed''. Note that the lyophilized product prepared in Example 3 was used as the coloring liquid. In addition, an enzyme reaction was performed on the lyophilized product with the addition of 70 mM ammonium oxalate and the lyophilized color former without any additive. The enzymatic reaction was carried out at room temperature in the light for 1 hour and at 4° C. overnight, and the former results are shown in FIG. 1 and the latter results are shown in FIG. 2. As is clear from these figures, on the low insulin concentration side, sensitivity is significantly improved and non-specific reactions are suppressed. Insulin standard products were measured according to the measurement method described in ``Study of changes over time after color development''. The color stability was examined to see how it changes depending on the presence or absence of the addition of various reducing substances, and the results are shown in Table 5. It also shows the change over time when the absorbance (492 nm) immediately after the reaction is stopped is taken as 100.
ãè¡šã
è¡šâïŒããæãããªããã«ãéå
æ§ç©è³ªãç¹ã«
ä¿®é
žãŸãã¯ãã®å¡©ãé
µçŽ åå¿ç³»ã«æ·»å ããŠããŠ
ããåè²å®å®æ§ã¯ãããªãããªãããšãããã€
ãã
枬å®äŸïŒ éé
žåæ°ŽçŽ ã®å®é
0.3ïŒ
ïœâããšãã¬ã³ãžã¢ãã³ã»ïŒå¡©é
žå¡©ïŒïŒ
ã
PEG+4000ããã³30ïœïŒã®èé
žãããªãŠã ãå«ã
ãªã³é
žç·©è¡æ¶²ïŒPHïŒ5.0ïŒ500ÎŒã«ã20UïŒmlã®
ãã«ãªãã·ããŒãŒæ°Žæº¶æ¶²ã50ÎŒå ããããã«é
é
žåæ°ŽçŽ æº¶æ¶²ïŒæ¿åºŠïŒïŒã10ã20mgïŒmlïŒ25ÎŒ
ãå ãã37âã30åéé
µçŽ åå¿çµäºåŸã1Nç¡«é
ž
ïŒmlã§åå¿åæ¢åŸã492nmã§ã®åžå
床ã枬å®ãã
æ€éç·ãäœæããããªããèé
žãããªãŠã ãå«ãŸ
ãªãäžèšç·©è¡æ¶²ã察ç
§ãšããŠæž¬å®ããããã®çµæ
ã¯ç¬¬ïŒå³ã«ç€ºããŠããããã®å³ããæãããªãã
ã«ãéç¹ç°çåå¿ãããããããæ床ã«ãããŠã
æ¹è¯ãããŠããããšããããã[Table] As is clear from Table 5, it was found that the color stability was not impaired even when a reducing substance, especially oxalic acid or its salt, was added to the enzyme reaction system. Measurement example 3 Quantification of hydrogen peroxide 0.3% o-phenylenediamine dihydrochloride 1%,
Add 50Ό of 20U/ml peroxidase aqueous solution to 500Ό of phosphate buffer (PH: 5.0) containing PEG + 4000 and 30mM sodium oxalate, and add 25Ό of hydrogen peroxide solution (concentration: 0, 10, 20mg/ml).
After the enzymatic reaction was completed at 37â for 30 minutes, the reaction was stopped with 2 ml of 1N sulfuric acid, and the absorbance at 492 nm was measured.
A calibration curve was created. Note that the above buffer solution containing no sodium oxalate was used as a control for measurement. The results are shown in Figure 3. As is clear from this figure, non-specific reactions are suppressed and sensitivity is also improved.
第ïŒå³ã¯ãåçµä¹Ÿç¥çºè²å€ïŒïœâããšãã¬ã³ãž
ã¢ãã³ã»ïŒå¡©é
žå¡©ïŒ10mgïŒmlãèé
žã¢ã³ã¢ããŠ
ã ïŒ70ïœïŒãPEG+4000ïŒ10mgïŒmlãããªãåçµ
也ç¥åïŒã«0.02ïŒ
éé
žåæ°ŽçŽ ãå«ãã¯ãšã³é
žâã
ãé
žç·©è¡æ¶²ïŒPHïŒ5.7ïŒ20mlã§æº¶è§£åŸçºè²æ¶²ãšãª
ãã宀枩ãææãïŒæéã®é
µçŽ åå¿ãããããšã«
ãã€ãŠãåŸãããã€ã³ã¹ãªã³ã®æ€éç·ã§ããã察
ç
§ãšããŠãèé
žã¢ã³ã¢ããŠã ãå«ãŸãªãåçµä¹Ÿç¥
çºè²å€ãã調補ããçºè²æ¶²ã§åŸãããã€ã³ã¹ãªã³
ã®æ€éç·ã瀺ãã第ïŒå³ã¯ç¬¬ïŒå³ãšçºè²æ¶²ãåäž
ã«ããŠãé
µçŽ åå¿æ¡ä»¶ãïŒâãïŒå€è¡ãªã€ããã®
ã§ãããããã«ã第ïŒå³ã¯çºè²å€ãšããŠã30ïœïŒ
ã®èé
žãããªãŠã ããã³ïŒïŒ
PEG+4000ãå«æã
ããïœâããšãã¬ã³ãžã¢ãã³ã»ïŒå¡©é
žå¡©ã䜿çš
ããé
µçŽ ãšããŠãã«ãªãã·ããŒãŒãçšããéé
žå
æ°ŽçŽ å®éçšã®æ€éç·ã§ããããªããçºè²å€ã«èé
ž
ãããªãŠã ãå«ãŸãªããã®ã察ç
§ãšããŠæž¬å®ã
ãã
第ïŒãïŒå³ã«ãããŠãâÂã
Figure 1 shows a lyophilized color former (lyophilized product consisting of o-phenylenediamine dihydrochloride: 10 mg/ml, ammonium oxalate: 70 mM, PEG + 4000: 10 mg/ml) containing 0.02% hydrogen peroxide. This is a calibration curve for insulin obtained by dissolving in 20 ml of citric acid-phosphate buffer (PH: 5.7), preparing a coloring solution, and performing an enzyme reaction at room temperature in the light for 1 hour. As a control, a calibration curve for insulin obtained with a coloring solution prepared from a freeze-dried coloring agent that does not contain ammonium oxalate is shown. In Figure 2, the enzyme reaction was carried out overnight at 4°C using the same coloring solution as in Figure 1. Furthermore, Figure 3 shows 30mM as a coloring agent.
of sodium oxalate and 1% PEG + 4000. This is a calibration curve for hydrogen peroxide determination using o-phenylenediamine dihydrochloride and peroxidase as the enzyme. Note that the measurement was performed using a coloring agent that did not contain sodium oxalate as a control. In Figures 1 to 3, ââ g
Claims (1)
ãŸãã¯ãã®å¡©ããã³æ°Žæº¶æ§é«ååååç©ãå«ãã
ãšãç¹åŸŽãšããå®å®ãªéé žåç©è³ªãŸãã¯éé žåé µ
çŽ æŽ»æ§æž¬å®è©Šè¬çšçºè²å€çµæç©ã1. A stable coloring agent composition for a peroxidant or a peroxidase activity measuring reagent, which comprises phenylenediamine or a derivative thereof, oxalic acid or a salt thereof, and a water-soluble polymer compound.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3482784A JPS60178354A (en) | 1984-02-25 | 1984-02-25 | Stable color forming composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3482784A JPS60178354A (en) | 1984-02-25 | 1984-02-25 | Stable color forming composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60178354A JPS60178354A (en) | 1985-09-12 |
JPH0462026B2 true JPH0462026B2 (en) | 1992-10-02 |
Family
ID=12425027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3482784A Granted JPS60178354A (en) | 1984-02-25 | 1984-02-25 | Stable color forming composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60178354A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2920471C (en) * | 2013-08-16 | 2021-03-16 | Hach Company | A chlorine analytical test element and a stabilized n,n-diethyl-p-phenylenediamine solution |
-
1984
- 1984-02-25 JP JP3482784A patent/JPS60178354A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60178354A (en) | 1985-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1320115C (en) | Diagnostic assay employing signal producing agent on support | |
US4647532A (en) | Method for determination of hydrogen peroxide by chemiluminescence analysis | |
US3979262A (en) | Compositions and methods for the determination of oxidizing agents | |
US4121975A (en) | Pretreatment of samples for polyiodothyronine assays | |
JPS63500672A (en) | Colorimetric assay for substances that can bind | |
US3595755A (en) | Detection of hydrogen peroxide | |
Morin et al. | Single Glucose OxidaseâPeroxidase reagent for two-minute determination of serum glucose | |
JP2935578B2 (en) | Competitive binding assay with improved linearity | |
JP4214648B2 (en) | Glycated protein measurement reagent | |
JPS60184385A (en) | Stabilized enzyme conjugate composition | |
US5096812A (en) | Assay method for gamma glutamyltransferase (GGT) in liquid blood and dried blood | |
JPH0462026B2 (en) | ||
JP3003152B2 (en) | Method for measuring free hemoglobin and reagent kit for measuring free hemoglobin used therefor | |
US4467030A (en) | Determination of the thyroxine-binding index in serum | |
US3278394A (en) | Method and composition for diagnosing glucose | |
JPH0248237B2 (en) | ||
JPS6178385A (en) | Stable peroxidase composition | |
Rani et al. | Discrete analysis of bile acid in serum and bile with 3âº-hydroxysteroid dehydrogenase and diaphorase immobilized onto alkylamine glass beads | |
JPH01104198A (en) | Method for increase analytical accuracy | |
JPS61249399A (en) | Diagnostic assay using microperoxidase | |
JP2585723B2 (en) | How to stop the reaction of the detection system | |
JPH0638757B2 (en) | Peroxidase or H Ⲡlower 2 ⌠O Ⲡlower 2 ⌠measuring method | |
JPS58143268A (en) | Determination of immunity suppresing acidic protein and kit thereof | |
CN117825707A (en) | TAT detection kit and preparation method thereof | |
JP2521074B2 (en) | How to regulate the immune response |